Cardlytics Inc (NASDAQ:CDLX) CFO David Thomas Evans sold 1,500 shares of the business’s stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $33.93, for a total transaction of $50,895.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.
David Thomas Evans also recently made the following trade(s):
- On Monday, July 15th, David Thomas Evans sold 1,500 shares of Cardlytics stock. The stock was sold at an average price of $28.14, for a total transaction of $42,210.00.
- On Monday, June 17th, David Thomas Evans sold 1,500 shares of Cardlytics stock. The stock was sold at an average price of $25.18, for a total transaction of $37,770.00.
NASDAQ:CDLX opened at $32.50 on Wednesday. Cardlytics Inc has a one year low of $9.80 and a one year high of $34.64. The firm’s fifty day moving average price is $29.61 and its two-hundred day moving average price is $21.59. The company has a current ratio of 2.01, a quick ratio of 2.01 and a debt-to-equity ratio of 0.79.
Cardlytics (NASDAQ:CDLX) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.12) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.35) by $0.23. Cardlytics had a negative net margin of 19.60% and a negative return on equity of 66.01%. The firm had revenue of $48.73 million for the quarter, compared to the consensus estimate of $43.77 million. During the same period in the previous year, the company earned ($0.21) earnings per share. The company’s quarterly revenue was up 37.0% on a year-over-year basis. On average, sell-side analysts forecast that Cardlytics Inc will post -1.08 EPS for the current fiscal year.
Several large investors have recently added to or reduced their stakes in CDLX. Bank of Montreal Can increased its holdings in shares of Cardlytics by 16,371.4% in the second quarter. Bank of Montreal Can now owns 1,153 shares of the company’s stock valued at $30,000 after purchasing an additional 1,146 shares during the last quarter. Oppenheimer Asset Management Inc. acquired a new position in shares of Cardlytics in the second quarter valued at $60,000. Rockefeller Capital Management L.P. acquired a new position in shares of Cardlytics in the second quarter valued at $85,000. Acadian Asset Management LLC acquired a new position in shares of Cardlytics in the second quarter valued at $161,000. Finally, Gamco Investors INC. ET AL acquired a new position in shares of Cardlytics in the first quarter valued at $256,000. Hedge funds and other institutional investors own 75.09% of the company’s stock.
A number of equities analysts recently weighed in on CDLX shares. Raymond James boosted their target price on shares of Cardlytics from $24.00 to $40.00 and gave the stock an “outperform” rating in a report on Friday, August 9th. ValuEngine downgraded shares of Cardlytics from a “strong-buy” rating to a “buy” rating in a report on Tuesday, April 23rd. William Blair started coverage on shares of Cardlytics in a report on Monday, July 1st. They set an “outperform” rating on the stock. Bank of America restated a “buy” rating and set a $32.00 target price (up from $22.00) on shares of Cardlytics in a report on Wednesday, July 24th. Finally, SunTrust Banks boosted their target price on shares of Cardlytics from $25.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, August 9th. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $33.29.
Cardlytics Company Profile
Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.
Featured Article: When can a hold rating present a buying opportunity?
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.